Chromosomal amplification is associated with cisplatin resistance of human male germ cell tumors

Cancer Research

Volumn 58, Issue 19, 1998, Pages 4260-4263

  Rao, Pulivarthi H ^a   Houldsworth, Jane ^a   Palanisamy, Nallasivam ^a   Murty, V V V S ^b   Reuter, Victor E ^a   Motzer, Robert J ^a   Bosl, George J ^a   Chaganti, R S K ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; PROTEIN P53;

ARTICLE; CANCER CHEMOTHERAPY; CANCER GENETICS; CHROMOSOME 12P; CHROMOSOME 15Q; CHROMOSOME 1Q; CHROMOSOME 20Q; CHROMOSOME 2P; CHROMOSOME 7Q; CHROMOSOME 9Q; GENE MUTATION; GERM CELL TUMOR; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CHROMOSOME MAPPING; CHROMOSOMES, HUMAN; CISPLATIN; DRUG RESISTANCE, NEOPLASM; GENE AMPLIFICATION; GERMINOMA; HUMANS; KARYOTYPING; MALE; TESTICULAR NEOPLASMS;

EID: 0032188788     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Bosl, G. J., and Motzer, R. J. Testicular germ-cell cancer. N. Engl. J. Med., 337: 242-253, 1997.
2. Chaganti, R. S. K., and Houldsworth, J. The cytogenetic theory of the pathogenesis of human adult male germ cell tumors. APMIS, 106: 80-84, 1998.
3. Samaniego, F., Rodriguez, E., Houldsworth, J., Murty, V. V. V. S., Ladanyi, M., Lele, K. P., Chen, Q., Dmitrovsky, E., Geller, N. L., Reuter, V., Jhanwar, S. C., Bosl, G. J., and Chaganti, R. S. K. Cytogenetic and molecular analysis of human male germ cell tumors: chromosome 12 abnormalities and gene amplification. Genes Chromosomes Cancer, 1: 289-300, 1990.
4. Albrecht, S., Armstrong, D. L., Mahoney, D. H., Cheek, W. R., and Cooley, L. D. Cytogenetic demonstration of gene amplification in a primary intracranial germ cell tumor. Genes Chromosomes Cancer, 6: 61-63, 1993.
5. Chaganti, R. S. K., Murty, V. V. V. S., Houldsworth, J., Rao, P. H., Rodriguez, E., and Bosl, G. J. Molecular genetics in germ cell tumours. Adv. Biosci., 91: 107-111, 1994.
6. Motzer, R. J., Mazumdar, M., Bajorin, D. F., Bosl, G. J., Lyn, P., and Vlamis, V. High-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors. J. Clin. Oncol., 15: 2546-2552, 1997.
7. Rao, P. H., Houldsworth, J., Dyomina, K., Parsa, N. Z., Cigudosa, J. C., Louie, D. C., Popplewell, L., Offit, K., Jhanwar, S. C., and Chaganti, R. S. K. Chromosomal and gene amplification in diffuse large B-cell lymphoma (DLBL). Blood, 92: 234-240, 1998.
8. Pastan, I., and Gottesman, M. Multiple-drug resistance in human cancer. N. Eng. J. Med., 316: 1388-1393, 1987.
9. Izquierdo, M. A., Shoemaker, R. H., Flens, M. J., Scheffer, G. L., Wu, L., Prather, T. R., and Scheper, R. J. Overlapping phenotypes of multidrug resistance among panels of human cancer-cell lines. Int. J. Cancer, 65: 230-237, 1996.
10. Borst, P., Kool, M., and Evers, R. Do cMOAT (MRP2), other MRP homologues, and LRP play a role in MDR? Semin. Cancer Biol., 8: 205-213, 1997.
11. Yang, E., and Korsmeyer, S. J. Molecular thanatopsis: A discourse on the BCL2 family and cell death. Blood, 88: 386-401, 1996.
12. Harris, C. C. p53 tumor suppressor gene: from the basic research laboratory to the clinic-an abridged historical perspective. Carcinogenesis (Lond.), 17: 1187-1198, 1996.
13. Bartkova, J., Bartek, J., Lukas, J., Voijesek, B., Staskova, Z., Rejthar, A., Kovarik, J., Midgley, C. A., and Lane, D. P. p53 protein alterations in human testicular cancer including pre-invasive intratubular germ-cell neoplasia. Int. J. Cancer, 49: 196-202, 1991.
14. Riou, G., Barrois, M., Prost, S., Terrier, M. J., Theodore, C., and Levine, A. J. The p53 and mdm-2 genes in human testicular germ-cell tumors. Mol. Carcinog., 12: 124-131, 1995.
15. Houldsworth, J., Xiao, H., Murty, V. V. V. S., Chen, W., Ray, B., Reuter, V. E., Bosl, G. J., and Chaganti, R. S. K. Human male germ cell tumor resistance to cisplatin is linked to TP53 gene mutation. Oncogene, 16: 2345-2349, 1998.
16. Schwab, M., and Amler, L. C. Amplification of cellular oncogenes: a predictor of clinical outcome in human cancer. Genes Chromosomes Cancer, 1: 181-193, 1990.
17. Lin, E. Y., Kozak, C. A., Orlofsky, A., and Prystowsky, M. B. The bcl-2 family member, Bcl2a1, maps to mouse chromosome 9 and human chromosome 15. Mamm. Genome, 8: 293-294, 1997.
18. D'Sa-Eipper, C., Subramanian, T., and Chinnadurai, G. bfl-1, a bcl-2 homologue, suppresses p53-induced apoptosis and exhibits potent cooperative transforming activity. Cancer Res., 56: 3879-3882, 1996.
19. Shuin, T., Misaki, H., Kubota, Y., Yao, M., and Hosaka, M. Differential expression of protooncogenes in human germ cell tumors of the testis. Cancer (Phila.), 73: 1721-1727, 1994.
20. Anzick, S. L., Kononen, J., Walker, R. L., Azorsa, D. O., Tanner, M. M., Guan, X-Y., Sauter, G., Kallioniemi, O-P., Trent, J. M., and Meltzer, P. S. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science (Washington DC), 277: 965-968, 1997.
21. Mostert, M. M., van de Pol, D., Weghuis, O., Suijkerbuijk, R. F., Geurts van Kessel, A., van Echten, J., Oosterhuis, J. W., and Looijenga, L. H. J. Comparative genomic hybridization of germ cell tumors of the adult testis: confirmation of karyotypic findings and identification of a 12p-amplicon. Cancer Genet. Cytogenet., 89: 146-152, 1996.
22. Suijkerbuijk, R. F., Sinke, R. J., Olde Weghuis, D. E. M., Roque, L., Forus, A., Stellink, F., Siepman, A., van de Kaa, C., Soares, J., and van Kessel, A. G. Amplification of chromosome subregion 12p11.2-p12.1 in a metastasis of an i(12p)-negative seminoma: relationship to tumor progression? Cancer Genet. Cytogenet., 78: 145-152, 1994.
23. Rodriguez, E., Reuter, V. E., Mies, C., Bosl, G. J., and Chaganti, R. S. K. Abnormalities of 2q: a common genetic link between rhabdomyosarcoma and hepatoblastoma? Genes Chromosomes Cancer, 3: 122-127, 1991.